Drugs

An entrepreneur with his own rare disease finds a way to align incentives and needs to support research on rare diseases.

As psychedelics are integrated into mainstream medicine, experts weigh the benefits and costs of solo versus group therapy.

Bone marrow transplants are harrowing. Agnieszka Czechowicz is working to make them safer.

DARPA is developing an implantable device with bioengineered cells for treating everything from traveler’s diarrhea to jet lag.

Forty years after a 1981 report hinted at the coming HIV/AIDS pandemic, we look at how the response to global public health threats has changed.

Cells we were taught to ignore have been caught on tape doing the unthinkable.

For the millions of people suffering with daily physical pain, nerve stimulation and gene editing offer new hope beyond addictive opioids.

Mushrooms are waiting for their moment in medicine.

Some tech and drug enhancements are banned as unfair, but ironically they could end up leveling the playing field.

Deep learning uncovers the potential of existing medications to target different diseases.

Low levels of the naturally occurring, soft shiny metal could reduce violence and enhance moods for all.

As Western medicine brings psychedelics into mainstream use, a growing movement is innovating new business models grounded in reciprocity and inclusion.

Syncing cures with circadian rhythms is an idea whose moment has finally come.

Space brain and other cosmic problems demand new kinds of pharmaceutical protection.

Gene tests for antidepressants are going mainstream — and getting more confusing. Here’s a guide.